文献
J-GLOBAL ID:201902277545481472
整理番号:19A1089209 抗インテグリン製剤
Anti-integrin therapy for inflammatory bowel disease
- 1) Hynes RO: Integrins:a family of cell surface receptors. Cell 48; 549-554: 1987
- 2) Gorfu G, Rivera-Nieves J, Ley K: Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med 9; 836-850: 2009
- 3) Briskin M, Winsor-Hines D, Shyjan A, et al: Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 151; 97-110: 1997
- 4) Berlin C, Berg EL, Briskin MJ, et al: Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74; 185-195: 1993
- 5) Erle DJ, Briskin MJ, Butcher EC, et al: Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. J Immunol 153; 517-528: 1994
- 6) Meenan J, Spaans J, Grool TA, et al: Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut 40; 241-246: 1997
- 7) Connor EM, Eppihimer MJ, Morise Z, et al: Expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in acute and chronic inflammation. J Leukoc Biol 65; 349-355: 1999
- 8) Ogawa H, Binion DG, Heidemann J, et al: Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells. Am J Physiol Cell Physiol 288; C272-C281: 2005
- 9) Rivera-Nieves J, Olson T, Bamias G, et al: L-selectin, alpha 4 beta 1, and alpha 4 beta 7 integrins participate in CD4+ T cell recruitment to chronically inflamed small intestine. J Immunol 174; 2343-2352: 2005
- 10) Arihiro S, Ohtani H, Suzuki M, et al: Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease. Pathol Int 52; 367-374: 2002
- 11) Wagner N, Löhler J, Kunkel EJ, et al: Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 382; 366-370: 1996
- 12) Wang C, Hanly EK, Wheeler LW, et al: Effect of α4β7 blockade on intestinal lymphocyte subsets and lymphoid tissue development. Inflamm Bowel Dis 16; 1751-1762: 2010
- 13) Picarella D, Hurlbut P, Rottman J, et al: Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells. J Immunol 158; 2099-2106: 1997
- 14) Podolsky DK, Lobb R, King N, et al: Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody. J Clin Invest 92; 372-380: 1993
- 15) Hesterberg PE, Winsor-Hines D, Briskin MJ, et al: Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7. Gastroenterology 111; 1373-1380: 1996
- 16) de Lange KM, Moutsianas L, Lee JC, et al: Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet 49; 256-261: 2017
- 17) Zeissig S, Rosati E, Dowds CM, et al: Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease. Gut 68; 25-39: 2019
- 18) Elices MJ, Osborn L, Takada Y, et al: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60; 577-584: 1990
- 19) Sandborn WJ, Colombel JF, Enns R, et al: Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med 353; 1912-1925: 2005
- 20) Targan SR, Feagan BG, Fedorak RN, et al: Natalizumab for the treatment of active Crohn's disease:results of the ENCORE Trial. Gastroenterology 132; 1672-1683: 2007
前のページに戻る